249 related articles for article (PubMed ID: 7991123)
21. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters.
Mosser J; Douar AM; Sarde CO; Kioschis P; Feil R; Moser H; Poustka AM; Mandel JL; Aubourg P
Nature; 1993 Feb; 361(6414):726-30. PubMed ID: 8441467
[TBL] [Abstract][Full Text] [Related]
22. The cystathionine beta-synthase variant c.844_845ins68 protects against CNS demyelination in X-linked adrenoleukodystrophy.
Linnebank M; Semmler A; Kleijer WJ; van der Sterre ML; Gärtner J; Fliessbach K; Sokolowski P; Köhler W; Schlegel U; Klockgether T; Wanders RJ; Schmidt S; Wüllner U; Kemp S
Hum Mutat; 2006 Oct; 27(10):1063-4. PubMed ID: 16941496
[TBL] [Abstract][Full Text] [Related]
23. Genetic variants of methionine metabolism and X-ALD phenotype generation: results of a new study sample.
Semmler A; Bao X; Cao G; Köhler W; Weller M; Aubourg P; Linnebank M
J Neurol; 2009 Aug; 256(8):1277-80. PubMed ID: 19353223
[TBL] [Abstract][Full Text] [Related]
24. Cerebral inflammation in X-linked adrenoleukodystrophy.
McGuinness MC; Smith KD
Arch Immunol Ther Exp (Warsz); 1999; 47(5):281-7. PubMed ID: 10604233
[TBL] [Abstract][Full Text] [Related]
25. Linkage of DNA markers at Xq28 to adrenoleukodystrophy and adrenomyeloneuropathy present within the same family.
Willems PJ; Vits L; Wanders RJ; Coucke PJ; Van der Auwera BJ; Van Elsen AF; Raeymaekers P; Van Broeckhoven C; Schutgens RB; Dacremont G
Arch Neurol; 1990 Jun; 47(6):665-9. PubMed ID: 2161209
[TBL] [Abstract][Full Text] [Related]
26. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy.
Asheuer M; Bieche I; Laurendeau I; Moser A; Hainque B; Vidaud M; Aubourg P
Hum Mol Genet; 2005 May; 14(10):1293-303. PubMed ID: 15800013
[TBL] [Abstract][Full Text] [Related]
27. CD1 gene polymorphisms and phenotypic variability in X-linked adrenoleukodystrophy.
Barbier M; Sabbagh A; Kasper E; Asheuer M; Ahouansou O; Pribill I; Forss-Petter S; Vidaud M; Berger J; Aubourg P
PLoS One; 2012; 7(1):e29872. PubMed ID: 22253809
[TBL] [Abstract][Full Text] [Related]
28. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations.
Kemp S; Pujol A; Waterham HR; van Geel BM; Boehm CD; Raymond GV; Cutting GR; Wanders RJ; Moser HW
Hum Mutat; 2001 Dec; 18(6):499-515. PubMed ID: 11748843
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis and genotype-phenotype correlation of 29 unrelated Japanese patients with X-linked adrenoleukodystrophy.
Takano H; Koike R; Onodera O; Sasaki R; Tsuji S
Arch Neurol; 1999 Mar; 56(3):295-300. PubMed ID: 10190819
[TBL] [Abstract][Full Text] [Related]
30. Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy.
Moser HW
J Neuropathol Exp Neurol; 1995 Sep; 54(5):740-5. PubMed ID: 7666063
[TBL] [Abstract][Full Text] [Related]
31. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.
Moser HW; Moser AE; Singh I; O'Neill BP
Ann Neurol; 1984 Dec; 16(6):628-41. PubMed ID: 6524872
[TBL] [Abstract][Full Text] [Related]
32. Newborn Screening for X-Linked Adrenoleukodystrophy in Nebraska: Initial Experiences and Challenges.
Baker CV; Cady Keller A; Lutz R; Eveans K; Baumert K; DiPerna JC; Rizzo WB
Int J Neonatal Screen; 2022 Apr; 8(2):. PubMed ID: 35645283
[TBL] [Abstract][Full Text] [Related]
33. The genotype and phenotype studies of 40 Chinese patients with X-linked adrenoleukodystrophy (X-ALD).
Ping LL; Bao XH; Wang AH; Pan H; Wu Y; Xiong H; Zhang YH; Jiang YW; Qin J; Wu XR
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 38(1):66-70. PubMed ID: 16415970
[TBL] [Abstract][Full Text] [Related]
34. [Adrenoleukodystrophy and adrenomyeloneuropathy. Clinical biochemical and molecular genetic findings].
Vorgerd M; Benkmann HG; Tegenthoff M; Gal A; Malin JP
Nervenarzt; 1998 Feb; 69(2):174-9. PubMed ID: 9551465
[TBL] [Abstract][Full Text] [Related]
35. X-linked adrenoleukodystrophy in a chimpanzee due to an ABCD1 mutation reported in multiple unrelated humans.
Curiel J; Steinberg SJ; Bright S; Snowden A; Moser AB; Eichler F; Dubbs HA; Hacia JG; Ely JJ; Bezner J; Gean A; Vanderver A
Mol Genet Metab; 2017 Nov; 122(3):130-133. PubMed ID: 28919002
[TBL] [Abstract][Full Text] [Related]
36. Adrenoleukodystrophy: phenotypic variability and implications for therapy.
Moser HW; Moser AB; Smith KD; Bergin A; Borel J; Shankroff J; Stine OC; Merette C; Ott J; Krivit W
J Inherit Metab Dis; 1992; 15(4):645-64. PubMed ID: 1528023
[TBL] [Abstract][Full Text] [Related]
37. Clinical course and endocrine dysfunction in X-linked adrenoleukodystrophy: A case series.
Matos T; Costa C; Araújo AN; do Vale S
Endocrinol Diabetes Nutr (Engl Ed); 2023; 70(6):421-428. PubMed ID: 37356877
[TBL] [Abstract][Full Text] [Related]
38. Auditory brainstem response findings and peripheral auditory sensitivity in adrenoleukodystrophy.
Pillion JP; Kharkar S; Mahmood A; Moser H; Shimizu H
J Neurol Sci; 2006 Sep; 247(2):130-7. PubMed ID: 16737712
[TBL] [Abstract][Full Text] [Related]
39. Retrospective evaluation of patients with X-linked adrenoleukodystrophy with a wide range of clinical presentations: a single center experience.
Olgac A; Kasapkara ÇS; Derinkuyu B; Yüksel D; Çetinkaya S; Aksoy A; Ceylaner S; Güleray N; Yeşilipek A; Aydın Hİ; Orgun LT; Kılıç M
J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1169-1179. PubMed ID: 34162029
[TBL] [Abstract][Full Text] [Related]
40. Mutations in the gene for X-linked adrenoleukodystrophy in patients with different clinical phenotypes.
Braun A; Ambach H; Kammerer S; Rolinski B; Stöckler S; Rabl W; Gärtner J; Zierz S; Roscher AA
Am J Hum Genet; 1995 Apr; 56(4):854-61. PubMed ID: 7717396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
